Showing results (1491-1500 of 1,657) with videos related to

Sort By:
Pageof 166
Nature Genetics|July 31, 2019
CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activationFatemehsadat Esteghamat, James S Broughton, Emily Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP InhibitorsJonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 14, 2018
Genetic variants in the LAMA5 gene in pediatric nephrotic syndromeDaniela A Braun, Jillian K Warejko, Shazia Ashraf, et al.
Nature|February 15, 2021
CTLA-4 blockade drives loss of T<sub>reg</sub> stability in glycolysis-low tumoursRoberta Zappasodi, Inna Serganova, Ivan J Cohen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2014
Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinomaC Christofer Juhlin, Gerald Goh, James M Healy, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Pageof 166